[使用真实世界数据,模型和网络药理学的综合药物发现策略]
Hirofumi Hamano1, Yuta Tanaka2, Yoshito Zamami1
1Department of Pharmacy, Medical Development Field, Okayama University.
这项研究将现实世界数据,查和网络药理学整合起来, 它确定了潜在的药物重新定位候选者和各种疾病的缓解安全性的治疗方法.
科学领域:
- 计算生物学
- 药理学
- 生物信息学
背景情况:
- 免疫检查点抑制剂可能导致心肌炎.
- 在HER2阳性乳腺癌中,特拉斯图祖马布耐药性是一个挑战.
- 药物诱导的周围神经病是某些药物的重要副作用.
研究的目的:
- 评估综合药物发现策略,结合现实数据,选和网络药理学.
- 确定针对特定药物不良反应和耐药癌症的潜在治疗干预措施和降低风险的策略.
- 在药物发现中展示多层次数据驱动方法的实用性.
主要方法:
- 对转录组数据和不良事件报告进行分析,以研究心肌炎.
- 化学信息学,机器学习和对接模拟用于药物的选.
- 对基因模块进行基于网络的分析,以调查药物诱导的外围神经病变.
主要成果:
- 针对酸代谢的非类固醇抗炎药物可以预防心肌炎.
- 新的YES1激酶抑制剂被确定为对特斯图祖马布耐药的乳腺癌.
- 通过共享的标和神经退行性途径,某些类药物可以防止药物诱导的外周神经病变.
结论:
- 整合各种数据模式 (转录组学,化学结构,网络,现实数据) 便于药物发现.
- 这种数据驱动的策略可以识别降低风险的药物重新定位候选药物和疗法.
- 多层次的方法有望发展以疗效和安全为重点的转化药物发现框架.
更多相关视频
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
相关概念视频
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Analysis of Population Pharmacokinetic Data
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
